Article
A systematic method for detecting abnormal mRNA splicing and assessing its clinical impact in individuals undergoing genetic testing for hereditary cancer syndromes
2022-07-14
Abstract excerpt
<h4>ABSTRACT</h4> Nearly 14% of disease-causing germline variants result from disruption of mRNA splicing. Most (67%) DNA variants predicted in silico to disrupt splicing end up classified as variants of uncertain significance (VUS). We developed and validated an analytic workflow — Sp lice E ffect E vent R esolver (SPEER) — that uses mRNA sequencing to reveal significant deviations in splicing, pinpoints th...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 71a946c1-1a57-5a12-90a7-c2a6ac6528e6
- DOI
- 10.1101/2022.07.12.499782
